Jessica Tassan

Stock Analyst at Piper Sandler

(0.99)
# 3,767
Out of 4,913 analysts
73
Total ratings
25.86%
Success rate
-10.26%
Average return

Stocks Rated by Jessica Tassan

Hinge Health
Jun 16, 2025
Initiates: Overweight
Price Target: $41
Current: $45.35
Upside: -9.59%
Oscar Health
Jun 9, 2025
Maintains: Overweight
Price Target: $25$18
Current: $14.70
Upside: +22.45%
UnitedHealth Group
Jun 3, 2025
Maintains: Overweight
Price Target: $552$353
Current: $282.15
Upside: +25.11%
Claritev
May 29, 2025
Upgrades: Overweight
Price Target: $19$44
Current: $40.13
Upside: +9.66%
American Well
May 23, 2025
Reiterates: Neutral
Price Target: $10$8
Current: $8.76
Upside: -8.62%
Premier
May 21, 2025
Maintains: Neutral
Price Target: $19$24
Current: $21.14
Upside: +13.53%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $348$374
Current: $292.21
Upside: +27.99%
CVS Health
Mar 21, 2025
Maintains: Overweight
Price Target: $72$74
Current: $59.64
Upside: +24.08%
Alignment Healthcare
Mar 4, 2025
Maintains: Overweight
Price Target: $14$21
Current: $11.87
Upside: +76.99%
Teladoc Health
Feb 27, 2025
Maintains: Overweight
Price Target: $13$12
Current: $8.20
Upside: +46.34%
Reiterates: Overweight
Price Target: $17$16
Current: $9.65
Upside: +65.89%
Maintains: Overweight
Price Target: $12$8
Current: $4.09
Upside: +95.84%
Reiterates: Overweight
Price Target: $31$33
Current: $27.11
Upside: +21.73%
Maintains: Neutral
Price Target: $270$288
Current: $231.53
Upside: +24.39%
Maintains: Neutral
Price Target: $21$23
Current: $61.01
Upside: -62.30%
Downgrades: Neutral
Price Target: $66$70
Current: $29.05
Upside: +141.01%